ADMA Biologics, Inc. (ADMA)
USD 19.39
(3.8%)
USD 19.39
(3.8%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 88.21 Million USD | 150.16% |
| 2022 | 35.26 Million USD | 2905.68% |
| 2021 | 1.17 Million USD | 106.15% |
| 2020 | -19.07 Million USD | -87.8% |
| 2019 | -10.15 Million USD | 59.72% |
| 2018 | -25.2 Million USD | -293.66% |
| 2017 | -6.4 Million USD | -248.92% |
| 2016 | 4.3 Million USD | 50.04% |
| 2015 | 2.86 Million USD | 31.89% |
| 2014 | 2.17 Million USD | 108.13% |
| 2013 | 1.04 Million USD | 132.51% |
| 2012 | 449.06 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 38.91 Million USD | 25.94% |
| 2024 Q2 | 57.31 Million USD | 47.27% |
| 2023 Q4 | 30.89 Million USD | 25.34% |
| 2023 Q3 | 24.65 Million USD | 47.71% |
| 2023 FY | 88.21 Million USD | 150.16% |
| 2023 Q2 | 16.69 Million USD | 1.07% |
| 2023 Q1 | 16.51 Million USD | 16.48% |
| 2022 Q4 | 14.17 Million USD | 46.81% |
| 2022 Q3 | 9.65 Million USD | 24.29% |
| 2022 Q2 | 7.76 Million USD | 112.16% |
| 2022 Q1 | 3.66 Million USD | 4.29% |
| 2022 FY | 35.26 Million USD | 2905.68% |
| 2021 Q4 | 3.51 Million USD | 811.28% |
| 2021 FY | 1.17 Million USD | 106.15% |
| 2021 Q2 | -1 Million USD | 41.79% |
| 2021 Q3 | 385.33 Thousand USD | 138.46% |
| 2021 Q1 | -1.72 Million USD | 66.61% |
| 2020 Q2 | -5.7 Million USD | 13.9% |
| 2020 Q4 | -5.15 Million USD | -226.45% |
| 2020 FY | -19.07 Million USD | -87.8% |
| 2020 Q1 | -6.62 Million USD | -2019.11% |
| 2020 Q3 | -1.57 Million USD | 72.34% |
| 2019 Q2 | -3.93 Million USD | 33.12% |
| 2019 Q4 | 345.44 Thousand USD | 149.8% |
| 2019 FY | -10.15 Million USD | 59.72% |
| 2019 Q1 | -5.87 Million USD | 17.06% |
| 2019 Q3 | -693.71 Thousand USD | 82.35% |
| 2018 Q3 | -4.93 Million USD | 1.11% |
| 2018 FY | -25.2 Million USD | -293.66% |
| 2018 Q1 | -8.2 Million USD | -10353.75% |
| 2018 Q2 | -4.98 Million USD | 39.16% |
| 2018 Q4 | -7.08 Million USD | -43.62% |
| 2017 Q1 | 1.01 Million USD | -22.89% |
| 2017 Q4 | 79.97 Thousand USD | 101.22% |
| 2017 Q3 | -6.56 Million USD | -602.07% |
| 2017 FY | -6.4 Million USD | -248.92% |
| 2017 Q2 | -934.61 Thousand USD | -192.3% |
| 2016 FY | 4.3 Million USD | 50.04% |
| 2016 Q1 | 857.46 Thousand USD | -15.06% |
| 2016 Q2 | 927.5 Thousand USD | 8.17% |
| 2016 Q4 | 1.31 Million USD | 9.24% |
| 2016 Q3 | 1.2 Million USD | 29.61% |
| 2015 FY | 2.86 Million USD | 31.89% |
| 2015 Q4 | 1 Million USD | 36.48% |
| 2015 Q3 | 739.63 Thousand USD | 41.25% |
| 2015 Q2 | 523.61 Thousand USD | -11.77% |
| 2015 Q1 | 593.47 Thousand USD | 11.58% |
| 2014 Q2 | 559.5 Thousand USD | -4.12% |
| 2014 Q4 | 531.89 Thousand USD | 6.75% |
| 2014 Q1 | 583.52 Thousand USD | 311.97% |
| 2014 Q3 | 498.24 Thousand USD | -10.95% |
| 2014 FY | 2.17 Million USD | 108.13% |
| 2013 FY | 1.04 Million USD | 132.51% |
| 2013 Q3 | 381.09 Thousand USD | 47.99% |
| 2013 Q4 | 141.64 Thousand USD | -62.83% |
| 2013 Q2 | 257.5 Thousand USD | -2.42% |
| 2013 Q1 | 263.88 Thousand USD | 84.55% |
| 2012 FY | 449.06 Thousand USD | 0.0% |
| 2012 Q1 | 4400.00 USD | 198.24% |
| 2012 Q3 | 215.64 Thousand USD | 144.43% |
| 2012 Q4 | 142.98 Thousand USD | -33.69% |
| 2012 Q2 | 88.22 Thousand USD | 1905.14% |
| 2011 Q2 | - USD | 100.0% |
| 2011 Q1 | -1060.00 USD | 23.13% |
| 2011 Q3 | -1325.00 USD | 0.0% |
| 2011 Q4 | -4479.00 USD | -238.04% |
| 2011 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | -794.00 USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | -1379.00 USD | -73.68% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -77.59 Million USD | 213.686% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 760.421% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1938.641% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 18030.488% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -17029.709% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 190.993% |
| Agenus Inc. | 139.61 Million USD | 36.813% |
| Fortress Biotech, Inc. | 57.85 Million USD | -52.486% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 61661.328% |
| Novavax, Inc. | 639.93 Million USD | 86.215% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 13385.843% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -318.869% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2489.437% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -202.853% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 26.774% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 94.188% |
| AlloVir, Inc. | -398 Thousand USD | 22265.326% |
| Aptorum Group Limited | -1.11 Million USD | 8014.143% |
| Ardelyx, Inc. | 106.66 Million USD | 17.291% |
| Bicycle Therapeutics plc | -129.52 Million USD | 168.111% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -73414.999% |
| Chimerix, Inc. | 324 Thousand USD | -27127.777% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 383.043% |
| CRISPR Therapeutics AG | 240.95 Million USD | 63.388% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1020.798% |
| Precision BioSciences, Inc. | 40.47 Million USD | -117.973% |
| Dyadic International, Inc. | 922.95 Thousand USD | -9458.192% |
| Elevation Oncology, Inc. | -39 Thousand USD | 226299.997% |
| Fortress Biotech, Inc. | 57.85 Million USD | -52.486% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 93.583% |
| Immix Biopharma, Inc. | -5468.00 USD | 1613450.384% |
| Innoviva, Inc. | 261.06 Million USD | 66.208% |
| IO Biotech, Inc. | -756 Thousand USD | 11769.047% |
| Jaguar Health, Inc. | 7.72 Million USD | -1042.128% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 26.333% |
| ContextLogic Inc. | 59 Million USD | -49.522% |
| AbCellera Biologics Inc. | 38.02 Million USD | -132.0% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 50555.551% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 160496.362% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 63.355% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 16839.658% |
| MEI Pharma, Inc. | 49.32 Million USD | -78.843% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -10899.75% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -203.624% |
| NextCure, Inc. | -3.68 Million USD | 2494.625% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -432.171% |
| ChromaDex Corporation | 50.78 Million USD | -73.726% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 183.128% |
| Incyte Corporation | 3.44 Billion USD | 97.436% |
| Opthea Limited | 21.72 Thousand USD | -406060.216% |
| MiMedx Group, Inc. | 266.84 Million USD | 66.94% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 199742.435% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -309.459% |
| Psyence Biomedical Ltd. | -240.00 USD | 36757599.583% |
| Vaxcyte, Inc. | -75 Million USD | 217.624% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 153988.286% |
| Pharming Group N.V. | 220.1 Million USD | 59.92% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -8643.112% |
| Onconetix, Inc. | -1.12 Million USD | 7926.538% |
| Acelyrin, Inc. | -115 Thousand USD | 76811.303% |
| PureTech Health plc | -1.6 Million USD | 5603.306% |
| Pyxis Oncology, Inc. | -2 Million USD | 4510.9% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 148.63% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 17171.83% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 74551.223% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 19.635% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -363.257% |
| Seer, Inc. | 7.02 Million USD | -1155.415% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 294.634% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 501.228% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 877803.701% |
| Summit Therapeutics Inc. | -2.05 Million USD | 4403.317% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 15549.737% |
| Senti Biosciences, Inc. | -2.68 Million USD | 3388.036% |
| ImmuCell Corporation | 4.39 Million USD | -1906.649% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 189.819% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 288.343% |
| Precigen, Inc. | 106 Thousand USD | -83124.527% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1764459.98% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 404.536% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2077.684% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 34.783% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2337.872% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -200.194% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1915.03% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -17685.887% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -20706.132% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 107682.926% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 15.256% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 189.869% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 38125.0% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -14385.714% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 71.876% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -3327.273% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 173962.828% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1342.857% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 18690.018% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 848349.99% |
| Soligenix, Inc. | 97.31 Thousand USD | -90555.732% |
| Century Therapeutics, Inc. | -10.8 Million USD | 916.153% |
| Kura Oncology, Inc. | -849 Thousand USD | 10490.813% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 231.465% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 60112.244% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 10.926% |
| Autolus Therapeutics plc | -4.86 Million USD | 1912.574% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -113.159% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 52610.714% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 6.867% |
| GRI Bio, Inc. | 10.84 Million USD | -713.744% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -3373.169% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1115.517% |
| IGM Biosciences, Inc. | -211.66 Million USD | 141.679% |
| INmune Bio, Inc. | 155 Thousand USD | -56814.838% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -42.427% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 5956.637% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 13704.357% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 301452.733% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -21844.776% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 4519.739% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 28284.664% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 6.609% |
| Verastem, Inc. | -62 Thousand USD | 142387.095% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -3522.916% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 33900.0% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -2814.371% |
| Histogen Inc. | 3.76 Million USD | -2240.621% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -15210.867% |
| Surrozen, Inc. | -27.23 Million USD | 423.974% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1737.001% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 7421.725% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 443.97% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -339.946% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 4455554.495% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1354.201% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 131511.716% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 43.008% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -60406.172% |
| Apollomics, Inc. | 127 Thousand USD | -69362.991% |
| Amarin Corporation plc | 165.54 Million USD | 46.709% |
| Mesoblast Limited | -9.81 Million USD | 998.808% |
| Turnstone Biologics Corp. | 16.5 Million USD | -434.46% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 179.843% |
| Synaptogenix, Inc. | -6347.00 USD | 1390016.48% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 173076.469% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 45.33% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 94.981% |
| Better Therapeutics, Inc. | -2.72 Million USD | 3332.613% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 178.653% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 73.906% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 773399.43% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1509.233% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 8061.913% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1105.493% |
| Insmed Incorporated | 239.63 Million USD | 63.187% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2365.567% |
| OmniAb, Inc. | 14.66 Million USD | -501.473% |
| Alector, Inc. | -95.05 Million USD | 192.809% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 29.774% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 302.973% |
| Zai Lab Limited | 170.9 Million USD | 48.381% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -7.745% |
| Aura Biosciences, Inc. | -1.29 Million USD | 6912.201% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -67759.999% |
| Immunic, Inc. | -111 Thousand USD | 79575.675% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -456.44% |
| Veracyte, Inc. | 248.14 Million USD | 64.449% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.262% |
| FibroGen, Inc. | 128.9 Million USD | 31.563% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 15641589.184% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 856.14% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 97.404% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -22578.149% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 75.174% |
| TG Therapeutics, Inc. | 219.1 Million USD | 59.738% |
| Galecto, Inc. | -830 Thousand USD | 10728.675% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 6469.531% |
| Fortrea Holdings Inc. | 424 Million USD | 79.194% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 202.38% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 15658.73% |
| XBiotech Inc. | -1.74 Million USD | 5158.372% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 8061.913% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 289.835% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 216.792% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -20.183% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -425.013% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 77.324% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 277.69% |
| Vaxxinity, Inc. | -2.23 Million USD | 4048.881% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 73.001% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 879.047% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -260.795% |
| NexImmune, Inc. | -1.02 Million USD | 8706.869% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1633566.648% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1341.518% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.219% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 132109.516% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 2584.314% |
| Ainos, Inc. | -253.73 Thousand USD | 34868.043% |
| Pluri Inc. | 322 Thousand USD | -27296.894% |
| Prothena Corporation plc | -129.2 Million USD | 168.28% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -74.953% |
| Celularity Inc. | 6.75 Million USD | -1205.966% |
| Rallybio Corporation | -150 Thousand USD | 58911.999% |
| Cue Biopharma, Inc. | -32.6 Million USD | 370.549% |
| MeiraGTx Holdings plc | 287 Thousand USD | -30637.979% |
| Omeros Corporation | -69.77 Million USD | 226.425% |
| Humacyte, Inc. | -76.55 Million USD | 215.242% |
| Immunocore Holdings plc | 248.39 Million USD | 64.484% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 681.568% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -41.416% |
| Blueprint Medicines Corporation | 236.58 Million USD | 62.712% |
| CalciMedica, Inc. | -58 Thousand USD | 152199.998% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 6286.395% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3201.899% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 385.819% |
| Pulmatrix, Inc. | -8.22 Million USD | 1173.212% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 7640.0% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 22209.774% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 122.121% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3078.357% |
| Cytokinetics, Incorporated | -322.59 Million USD | 127.347% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -10132.86% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 25970.381% |
| Vor Biopharma Inc. | -3.49 Million USD | 2626.289% |
| Roivant Sciences Ltd. | 109.23 Million USD | 19.24% |
| Evogene Ltd. | 1.39 Million USD | -6205.79% |
| ProKidney Corp. | -3.16 Million USD | 2883.78% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 300.897% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1186.539% |
| CorMedix Inc. | -205.56 Thousand USD | 43015.519% |
| BioLineRx Ltd. | 1.1 Million USD | -7861.913% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 212.135% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 267427.27% |
| Atai Life Sciences N.V. | -5000.00 USD | 1764459.98% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 72493.503% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 91993.749% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 6451.188% |
| Sagimet Biosciences Inc. | 2 Million USD | -4310.9% |
| MediciNova, Inc. | 979.7 Thousand USD | -8904.547% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 204.624% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 93398.079% |
| GeoVax Labs, Inc. | -20.72 Million USD | 525.747% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 63.924% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2199.929% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 89.887% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1087.961% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 28557.419% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 735249.992% |
| Absci Corporation | -41.84 Million USD | 310.801% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1764459.98% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 215.509% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 3684.64% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 58.726% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 9474.92% |
| Allakos Inc. | -6.14 Million USD | 1536.541% |
| Imunon, Inc. | -720 Thousand USD | 12352.415% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 227.86% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 81.463% |
| BioAtla, Inc. | -103.73 Million USD | 185.045% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 773399.43% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 49660.674% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 136.331% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 28465.916% |
| XOMA Corporation | 3.86 Million USD | -2184.848% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 225.873% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -496.309% |
| aTyr Pharma, Inc. | -2.38 Million USD | 3794.221% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -608.01% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 304299.997% |
| Viridian Therapeutics, Inc. | -1 Million USD | 8851.786% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -678599892.308% |
| Akari Therapeutics, Plc | -4000.00 USD | 2205549.975% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 86.149% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -45207.845% |
| UroGen Pharma Ltd. | 73.35 Million USD | -20.267% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 430.479% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -759744.953% |
| Orgenesis Inc. | -5.72 Million USD | 1640.926% |
| Entera Bio Ltd. | -56 Thousand USD | 157632.141% |
| GH Research PLC | -315 Thousand USD | 28105.714% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 46776.19% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 16903.428% |
| Xencor, Inc. | -85.26 Million USD | 203.469% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 40021.801% |
| Replimune Group, Inc. | -2.65 Million USD | 3422.712% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 8910.91% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 50.396% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -45207.845% |
| Portage Biotech Inc. | -54 Thousand USD | 163466.665% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 93398.079% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 23500.0% |
| OncoCyte Corporation | 413 Thousand USD | -21260.29% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1962680.623% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 39737937.387% |
| Purple Biotech Ltd. | -196 Thousand USD | 45109.183% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -883.698% |
| scPharmaceuticals Inc. | 9.78 Million USD | -801.84% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 944.599% |
| HilleVax, Inc. | -2.15 Million USD | 4191.744% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 91046.391% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 588063.203% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 13306.287% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 383656.517% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1175374.694% |
| Savara Inc. | -44.26 Million USD | 299.309% |
| Curis, Inc. | 9.81 Million USD | -799.174% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3085.315% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 70794.297% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 5202.256% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 38792.105% |
| BeiGene, Ltd. | 2.07 Billion USD | 95.756% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 3255.263% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 122.073% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -55.62% |
| Erasca, Inc. | -3.73 Million USD | 2463.826% |
| bluebird bio, Inc. | -4.03 Million USD | 2289.032% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 312730.232% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 95.368% |
| DBV Technologies S.A. | 15.72 Million USD | -460.898% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 312730.232% |
| Moderna, Inc. | 2.15 Billion USD | 95.906% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 9741.311% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1001.899% |
| Molecular Templates, Inc. | 50.39 Million USD | -75.053% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 16558.582% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 34.061% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1517.84% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 324.228% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 179.384% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 2558.696% |
| MacroGenics, Inc. | 50.52 Million USD | -74.596% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1546.671% |
| Prime Medicine, Inc. | -147.9 Million USD | 159.645% |
| Aditxt, Inc. | -111.66 Thousand USD | 79105.91% |
| Adagene Inc. | 18.11 Million USD | -387.083% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -17977.459% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 37.078% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 44.108% |
| SciSparc Ltd. | 2.19 Million USD | -3917.213% |
| Vericel Corporation | 135.57 Million USD | 34.931% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 352281.72% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 284839.523% |
| Generation Bio Co. | -73.91 Million USD | 219.357% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 20287.185% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -61.515% |
| Invivyd, Inc. | -2.02 Million USD | 4450.0% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 129.324% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 85385.871% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 8.457% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 10.245% |
| Clene Inc. | 533 Thousand USD | -16451.219% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -265.91% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 9318.182% |
| GeoVax Labs, Inc. | -20.72 Million USD | 525.747% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -4337.525% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 45499.246% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -77.127% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1343.909% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 10652.392% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -5.758% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -120561.45% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -65.942% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 150.938% |
| Trevena, Inc. | 1.45 Million USD | -5963.093% |
| Surrozen, Inc. | -27.23 Million USD | 423.974% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 25090.935% |
| Cingulate Inc. | -582.91 Thousand USD | 15233.861% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 284674.19% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 547.83% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1165463.263% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 10113.394% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 87.04% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 9028.947% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 156675.91% |
| Kronos Bio, Inc. | 1.37 Million USD | -6329.883% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 264.383% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 30311.643% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 18165.834% |
| ImmunityBio, Inc. | -17.89 Million USD | 593.113% |
| Korro Bio, Inc. | -3.63 Million USD | 2530.248% |
| Kineta, Inc. | 5.43 Million USD | -1523.744% |
| BioVie Inc. | -229.37 Thousand USD | 38559.828% |
| Codexis, Inc. | 57.33 Million USD | -53.867% |
| Celularity Inc. | 6.75 Million USD | -1205.966% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2098.305% |
| Celcuity Inc. | -142.77 Thousand USD | 61889.426% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -174278.334% |
| Cibus, Inc. | 1.42 Million USD | -6103.797% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 23687.7% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 484.912% |
| IN8bio, Inc. | -2.5 Million USD | 3627.309% |
| Kodiak Sciences Inc. | -25.94 Million USD | 439.993% |
| Annexon, Inc. | -3.26 Million USD | 2800.275% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 4415.949% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 311.366% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -13684.062% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 88.668% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 48.994% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 4743.053% |
| Arcellx, Inc. | 108.27 Million USD | 18.527% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 372.539% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -11.381% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 517.067% |
| Moolec Science SA | -143.3 Thousand USD | 61659.61% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 308.464% |
| Geron Corporation | -123.5 Million USD | 171.43% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -2583.845% |
| Royalty Pharma plc | 1.79 Billion USD | 95.082% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 225.864% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2442458.776% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -38025.078% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 179.18% |
| Humacyte, Inc. | -76.55 Million USD | 215.242% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 9394.186% |
| 89bio, Inc. | -273 Thousand USD | 32414.285% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 7118.138% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 10503.066% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 71821.95% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -7783.646% |
| Notable Labs, Ltd. | 113 Thousand USD | -77969.026% |
| Liquidia Corporation | 14.6 Million USD | -504.233% |
| Mustang Bio, Inc. | -2.22 Million USD | 4064.854% |
| Immunovant, Inc. | -231 Thousand USD | 38289.61% |
| Quantum-Si incorporated | 488 Thousand USD | -17977.459% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 258.783% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 294159.997% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -4637.809% |
| Acasti Pharma Inc. | -11 Thousand USD | 802081.809% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 43213.719% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 13704.357% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 152.664% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -7675.388% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 23254.33% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 4605.516% |
| PepGen Inc. | -1.18 Million USD | 7550.845% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 69562.991% |
| United Therapeutics Corporation | 2.07 Billion USD | 95.738% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 485.282% |
| Solid Biosciences Inc. | -76.56 Million USD | 215.223% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 106923.437% |
| Immuneering Corporation | -764.13 Thousand USD | 11644.773% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -133031.11% |
| Belite Bio, Inc | -399 Thousand USD | 22209.774% |
| XOMA Corporation | 3.86 Million USD | -2184.848% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 540.297% |
| Bionomics Limited | -434.44 Thousand USD | 20405.72% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 8313.966% |
| uniQure N.V. | 2.21 Million USD | -3882.754% |
| Cassava Sciences, Inc. | -89.42 Million USD | 198.652% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 195.817% |
| Forte Biosciences, Inc. | -9000.00 USD | 980299.989% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 10665.03% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 20287.185% |
| Altimmune, Inc. | -65.37 Million USD | 234.946% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 75.632% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 8313.966% |
| Compugen Ltd. | 31.45 Million USD | -180.458% |
| Peak Bio, Inc. | 367.76 Thousand USD | -23887.34% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -259.838% |
| Benitec Biopharma Inc. | 108 Thousand USD | -81583.332% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 113199.999% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 7433.167% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 4941.822% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 74232.772% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 7433.167% |
| Instil Bio, Inc. | -4.75 Million USD | 1954.878% |
| argenx SE | 1.1 Billion USD | 92.042% |
| Immunome, Inc. | -8.9 Million USD | 1090.434% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 4767.619% |
| Verona Pharma plc | -679.62 Thousand USD | 13080.413% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 50510.285% |
| Shattuck Labs, Inc. | -2.38 Million USD | 3798.868% |
| CervoMed Inc. | -1.29 Million USD | 6919.431% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 3765.06% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1946.724% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -3470.134% |
| Moolec Science SA | -143.3 Thousand USD | 61659.61% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 21720.469% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 3402.155% |
| AnaptysBio, Inc. | 14.78 Million USD | -496.834% |
| Design Therapeutics, Inc. | -537 Thousand USD | 16527.933% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 20759.953% |
| NeurAxis, Inc. | 2.15 Million USD | -3990.408% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4010.811% |
| Lumos Pharma, Inc. | 2 Million USD | -4295.516% |
| Achilles Therapeutics plc | -4.73 Million USD | 1964.575% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 50510.285% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 83580.482% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -178.653% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -10132.86% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 8648.256% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 293.681% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -205058.137% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 10832.117% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 670551.429% |
| Palisade Bio, Inc. | 246 Thousand USD | -35760.975% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 267427.27% |
| Beam Therapeutics Inc. | -59.67 Million USD | 247.838% |
| Neurogene Inc. | -3.26 Million USD | 2804.414% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 36.686% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -120.545% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 29803.03% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2290.643% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1022.204% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -526.548% |
| Athira Pharma, Inc. | -969 Thousand USD | 9204.025% |
| Vaccinex, Inc. | -16 Million USD | 651.225% |
| HCW Biologics Inc. | -574.82 Thousand USD | 15446.958% |
| XOMA Corporation | 3.86 Million USD | -2184.848% |
| Nektar Therapeutics | 53.47 Million USD | -64.961% |
| Arvinas, Inc. | 71.8 Million USD | -22.866% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 205.7% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 240.53% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 27496.894% |
| Rezolute, Inc. | -36 Thousand USD | 245149.997% |
| Clene Inc. | 533 Thousand USD | -16451.219% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 6870660.67% |
| BeyondSpring Inc. | 1.75 Million USD | -4938.15% |
| Synlogic, Inc. | -1.92 Million USD | 4685.135% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 238527.024% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1493.209% |
| Peak Bio, Inc. | 367.76 Thousand USD | -23887.34% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 565.211% |
| Krystal Biotech, Inc. | 47.6 Million USD | -85.312% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 37.474% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1655.582% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 3507.128% |
| MannKind Corporation | 136.19 Million USD | 35.225% |
| Ikena Oncology, Inc. | -50.49 Million USD | 274.717% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 18.928% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2111.813% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 35107.142% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1764459.98% |
| Legend Biotech Corporation | 140.92 Million USD | 37.403% |
| Mural Oncology plc | -2.56 Million USD | 3536.619% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 16110.526% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 88317.999% |
| Champions Oncology, Inc. | 20.75 Million USD | -325.065% |
| REGENXBIO Inc. | 53.02 Million USD | -66.358% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1746.794% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 45957.309% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 5193.418% |
| Vaxart, Inc. | -60.76 Million USD | 245.184% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 33671.048% |
| Cellectis S.A. | 18 Thousand USD | -489999.994% |
| Longeveron Inc. | 221 Thousand USD | -39817.647% |
| Repare Therapeutics Inc. | -80.07 Million USD | 210.176% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 91.929% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 6917.465% |
| Revolution Medicines, Inc. | -399.66 Million USD | 122.073% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 252151.426% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -179936.733% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.975% |
| Denali Therapeutics Inc. | -93.34 Million USD | 194.507% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 352281.72% |
| Veru Inc. | 7.56 Million USD | -1065.99% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 58522.516% |
| Cingulate Inc. | -582.91 Thousand USD | 15233.861% |
| Passage Bio, Inc. | -3.72 Million USD | 2470.814% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 732564.289% |
| Exicure, Inc. | -1.42 Million USD | 6299.438% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 23133.42% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3163.707% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 17307.392% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -29.492% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 59066.492% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 249.002% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -22462.148% |
| OmniAb, Inc. | 14.66 Million USD | -501.473% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -341.244% |
| Lipocine Inc. | -2.85 Million USD | 3194.48% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 4886.652% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1646.328% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 5956.637% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -17.13% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 135819.998% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -4.653% |
| Ocugen, Inc. | -33.53 Million USD | 363.047% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 2889.943% |
| Q32 Bio Inc. | 578 Thousand USD | -15162.63% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 33389.811% |
| Alumis Inc. Common Stock | -1.28 Million USD | 6970.561% |
| Equillium, Inc. | 35.95 Million USD | -145.336% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 5268.014% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -17519.672% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2134062.24% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 34161.003% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -20769.528% |
| Dominari Holdings Inc. | 2.03 Million USD | -4226.533% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 48182.803% |
| vTv Therapeutics Inc. | -13.59 Million USD | 748.9% |
| Bio-Techne Corporation | 773.07 Million USD | 88.589% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -409.371% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 80.855% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 7646.45% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 467.882% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -654.193% |
| Nkarta, Inc. | -5.86 Million USD | 1603.118% |
| BioCardia, Inc. | -7.24 Million USD | 1316.968% |
| Iterum Therapeutics plc | -1.75 Million USD | 5141.029% |